Jarden Corp. Archives - CDR – Chain Drug Review

Newell Brands sells tool business for $1.95 billion

October 12, 2016 by Chain Drug Review Jarden Corp., Michael Polk, Newell Brands, Stanley Black & Decker Business, Supplier News

HOBOKEN, N.J. — As part of its recently announced growth strategy, Newell Brands Inc. plans to sell its tool brands to Stanley Black & Decker in a $1.95 billion deal. Newell said Wednesday that the agreement includes its Irwin, Lenox and Hilmor brands. The company is retaining its Dymo Industrial labeling business, which was reported

Newell Rubbermaid Acquires Jarden

December 14, 2015 by Chain Drug Review CEO James Lillie, chief executive officer Michael Polk, cofounder Ian Ashken, Jarden Corp., Martin Franklin, Newell Rubbermaid Leading Headlines, Supplier News

ATLANTA — Newell Rubbermaid Inc. is buying Jarden Corp. for about $13.2 billion in cash and stock, combining brands including Paper Mate, Sunbeam and Yankee Candle. Jarden shareholders will receive, per share, $21 and 0.862 shares of Newell Rubbermaid stock at closing. Based on Newell Rubbermaid’s closing price on December 11, the implied total consideration